Stem Cell-Based Innovations for Neonatal Hypoxic-Ischemic Encephalopathy
Journal of Regenerative Medicine and Biology Research · 20.04.2026 · 7 (1) · 1-17
DOI: 10.46889/jrmbr.2026.7109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Regenerative Medicine and Biology Research, online erschienen am 20.04.2026. Verfasst von Harrison M McCredie und 1 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
Neonatal Hypoxic-Ischemic Encephalopathy (HIE) is a common brain injury initiated, during late gestation or labor, from reduced oxygen and blood supply to the brain. Currently, HIE poses high risk of mortality and development of long-term neurological disabilities among neonates. Despite advances in care, HIE continues to have a persistent incidence rate worldwide. Neurologically, injury promotes a cascade of events including energy failure, excitotoxicity, etc. that diminishes brain tissues. Diagnosis and staging of HIE includes clinical assessments, MRI imaging, as well as biomarkers that allows for treatment initiation to occur. Standard treatment with Therapeutic Hypothermia (TH) slows injury by cooling infant’s internal temperature to 33.5°C within a few hours. Despite success, increased rates of treatment-related complications resulting from TH highlight the need for alternative methods of treatment. Experimental studies using a variety of stem cells including MSCs have shown success in preclinical and early-phase trials with neuroprotection and regenerative potential present. These studies have small sample sizes and lack comparative data with consistent limitations to be addressed. Future research must identify an optimized protocol in which one cell type is used. Current findings have suggested combination treatments with stem cells and standard care show promising results, yet continued research is needed.
Zitieren
APA
McCredie, H. M., & Gallicchio, V. S. (2026). Stem Cell-Based Innovations for Neonatal Hypoxic-Ischemic Encephalopathy. Journal of Regenerative Medicine and Biology Research, 7(1), 1-17. https://doi.org/10.46889/jrmbr.2026.7109
Vancouver
McCredie HM, Gallicchio VS. Stem Cell-Based Innovations for Neonatal Hypoxic-Ischemic Encephalopathy. Journal of Regenerative Medicine and Biology Research. 2026;7(1):1-17. doi:10.46889/jrmbr.2026.7109
BibTeX
@article{McCredie2026,
author = {McCredie, Harrison M and Gallicchio, Vincent S},
title = {Stem Cell-Based Innovations for Neonatal Hypoxic-Ischemic Encephalopathy},
journal = {Journal of Regenerative Medicine and Biology Research},
year = {2026},
volume = {7},
number = {1},
pages = {1--17},
doi = {10.46889/jrmbr.2026.7109}
}
EUVIMED